Glucocorticoid receptor antagonists: New tools to investigate disorders characterized by cortisol hypersecretion

Stress

Volumn 7, Issue 4, 2004, Pages 233-241

  Peeters, B W M M ^a   Tonnaer, J A D M ^a   Groen, M B ^a   Broekkamp, C L E ^a   Van Der Voort, H A A ^a   Schoonen, W G F J ^a   Smets, R J M ^a   Vanderheyden, P M L ^a   Gebhard, R ^a   Ruigt, G S F ^a  

^a NV ORGANON   (Netherlands)

Author keywords

Antiglucocorticoid; Depression; HPA axis; Hypercortisolemia; Mineralocorticoid receptor; Progesterone receptor

Indexed keywords

11BETA (1,3 BENZODIOXOL 5 YL) 17BETA HYDROXY 17ALPHA (1 PROPYNYL)ESTRA 4,9 DIEN 3 ONE; ALDOSTERONE; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; HYDROCORTISONE; MIFEPRISTONE; MINERALOCORTICOID RECEPTOR; ORG 21863; ORG 34850; ORG 36174; ORG 36293; ORG 36294; ORG 36410; ORG 36411; ORG 36446; PLACEBO; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; BINDING AFFINITY; BRAIN; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOSOL; DEPRESSION; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; HIPPOCAMPUS; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL DISEASE; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT SURVEY;

ANIMALS; BLOOD-BRAIN BARRIER; HORMONE ANTAGONISTS; HUMANS; HYDROCORTISONE; MIFEPRISTONE; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RECEPTORS, PROGESTERONE;

EID: 20944443639     PISSN: 10253890     EISSN: None     Source Type: Journal    
DOI: 10.1080/10253890400019672     Document Type: Short Survey

References (102)

1. Abel, K.M., O'Keane, V. and Murray, R.M. (1996) Enhancement of the prolactin response to d-fenfluramine in drug-naïve schizophrenic patients, Br. J. Psychiat. 168, 57-60.
2. Acs, Z. and Start, E. (1975) Effect of cortexolone on the feedback action of dexamethasone, Experientia 31, 1365-1366.
3. Adaikan, P.G. and Kottegoda, S.R. (1984) RU486, Drugs Future 9, 755-756.
4. Adcock, I.M. (2003) Glucocorticoids: new mechanisms and future agents, Curr. Allergy Asthma Rep. 3, 249-257.
5. Agarwal, M.K., Sekiya, S. and Lazar, G. (1979a) Hormone-hormone antagonism in glucocorticoid action in vivo, Antihormones (Elsevier, North Holland, Amsterdam), pp 51-73.
6. Agarwal, M.K., Sekiya, S. and Lazar, G. (1979b) Search for anti-glucocorticoid activity in rat liver in vivo, Res. Exp. Med. 176, 181-192.
7. Alnemri, E.S., Maksymowych, A.B., Robertson, N.M. and Litwack, G. (1991) Overexpression and characterization of the human mineralocorticoid receptor, J. Biol. Chem. 266, 18072-18081.
8. Armanini, D., Spinella, P., Simoncini, M., Bassa, A., Zovato, S., Pozzan, G.B., DePalo, C.B., Bucciante, G. and Karbowiak, I. (1998) Regulation of corticosteroid receptors in patients with anorexia nervosa and Cushing's syndrome, J. Endocrinol. 158, 435-439.
9. Arnaldi, G., Angeli, A., Atkinson, A.B., Bertagna, X., Cavagnini, F., Chrousos, O.P., Fava, G.A., Findling, J.W., Gaillard, R.C., Grossman, A.B., Kola, B., Lacroix, A., Mancini, T., Mantero, F., Newell-Price, J., Nieman, L.K., Sonino, N., Vance, M.L., Giustina, A. and Boscaro, M. (2003) Diagnosis and complications of Cushing's syndrome: a consensus statement, J. Clin. Endocrinol. Metab. 88, 5593-5602.
10. Arriza, J.L., Weinberger, C., Cerelli, G., Glaser, T.M., Handelin, B.L., Housman, D.E. and Evans, R.M. (1987) Cloning of human mineralocorticoid receptor complementary DNA, structural and functional kinship with the glucocorticoid receptor, Science 237, 268-275.
11. Arriza, J.L., Simerly, R.B., Swanson, L.W. and Evans, R.M. (1988) The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response, Neuron 1, 887-900.
12. Baulieu, E.E. and Segal, S.J. (1984) The Antiprogestin Steroid RU486 and Human Fertility Control (Plenum Press, New York and London).
13. Belanoff, J.K., Gross, K., Yager, A. and Schatzberg, A.F. (2001) Corticosteroids and cognition, J. Psychiatr. Res. 35, 127-145.
14. Belanoff, J.K., Rothschild, A.J., Cassidy, F., DeBattista, C., Baulieu, E.E., Schold, C. and Schatzberg, A.F. (2002) An open label trial of C-1073 (mifepristone) for psychotic major depression, Biol. Psychiat. 52, 386-392.
15. Bertagna, X., Bertagna, C., Laudat, M.H., Husson, J.M. and Girard, F. (1986) Pituitary-adrenal response to the antiglucocorticoid action of RU486 in Cushing's syndrome, J. Clin. Endocrinol. Metab. 63, 639-642.
16. Binart, N., Lombes, M., Rafestin-Obelin, M.E. and Baulieu, E.E. (1991) Characterization of human mineralocorticoid receptor expressed in the baculovirus system, Proc. Natl Acad. Sci. USA 88, 10681-10685.
17. Brzozowski, A.M., Pike, A.C.W., Dauter, Z., Hubbard, R.E., Bonn, T., Engstrom, O., Ohman, L., Greene, G.L., Gustafsson, J.-A. and Carlquist, M. (1997) Molecular basis of agonism and antagonism in the oestrogen receptor, Nature 389, 753-758.
18. Butani, L. (2002) Corticosteroid-induced hypersensitivity reactions, Ann. Allergy Asthma Immunol. 89, 439-446.
19. Carnahan, M.C. and Goldstein, D.A. (2000) Ocular complications of topical, peri-ocular, and systemic corticosteroids, Curr. Opin. Ophthalmol. 11, 478-483.
20. Chan, O., Inouye, K., Riddell, M.C., Vranic, M. and Matthews, S.G. (2003) Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis, Minerva Endocrinol. 28, 87-102.
21. Chen, T.C., Mackic, J.B., McComb, J.G., Gianotta, S.L., Weiss, M.H. and Zlokovic, B.V. (1996) Cellular uptake and transport of methylprednisolone at the blood-brain barrier, Neurosurgery 38, 348-354.
22. Coghlan, M.J., Elmore, S.W., Kym, P.R. and Kort, M.E. (2003) The pursuit of differentiated ligands for the glucocorticoid receptor, Curr. Top. Med. Chem. 3, 1617-1635.
23. Dallman, M.F., la Fleur, S.E., Pecoraro, N.C., Gomez, F., Houshyar, H. and Akana, S.F. (2004) Minireview: glucocorticoids-food intake, abdominal obesity, and wealthy nations in 2004, Endocrinology 145, 2633-2638.
24. Dausse, J.P, Duval, D., Meyer, P., Gaignault, J.C., Marcandeau, C. and Raynaud, J.P. (1977) The relationship between glucocorticoid structure and effects upon thymocytes, Mol. Pharmacol. 13, 948-955.
25. Deraedt, R., Bonnat, C. and Busigny, M. (1985) Pharmacokinetics of RU486, In: Baulieu, E.E. and Segal, S., eds., The Antiprogestin Steroid RU486, and Human Fertility Control (New York: Plenum Press), pp 103-122.
26. Dinan, T.G. (1996) Noradrenergic and serotonergic abnormalities in depression, stress-induced dysfunction?, J. Clin. Psychiatry 57, 14-18.
27. Duax, W.L. and Griffin, J.F. (1984) Structural characteristics of antagonists for gluco- and mineralocorticoids, In: Agarwal, M.K., (ed.), Adrenal Steroid Antagonism (Walter de Gruyter, Berlin, New York), pp 15-41.
28. Duax, W.L., Griffin, J.F., Rohrer, D.C. and Weeks, C.H. (1982) Steroid antagonists, molecular conformation, receptor binding and activity, In: Agarwal, M.K. (ed.), Hormone Antagonists (Walter de Gruyter, Berlin), pp 3-24.
29. Evans, R.M. and Arriza, J.L. (1989) A molecular framework for the action of glucocorticoid hormones in the nervous system, Neuron 2, 1105-1112.
30. Frey, F.J., Odermatt, A. and Frey, B.M. (2004) Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension, Curr. Opin. Nephrol. Hypertens. 13, 451-458.
31. Gebhard, R., Van der Voort, H., Schuts, W. and Schoonen, W. (1997) 11,21-Bisphenyl-19-norpregnane derivatives are selective antiglucocorticoids, Bioorg. Med. Chem. Lett. 7, 2229-2234.
32. von Geldern, T.W., Tu, N., Kym, P.R., Link, J.T., Jae, H.S., Lai, C., Apelqvist, T., Rhonnstad, P., Hagberg, L., Koehler, K., Grynfarb, M., Goos-Nilsson, A., Sandberg, J., Osterlund, M., Barkhem, T., Hoglund, M., Wang, J., Fung, S., Wilcox, D., Nguyen, P., Jakob, C., Hutchins, C., Farnegardh, M., Kauppi, B., Ohman, L. and Jacobson, P.B. (2004) Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes, J. Med. Chem. 47, 4213-4230.
33. Giguere, V., Hollenberg, S.M., Rosenfeld, M.G. and Evans, R.M. (1986) Functional domains of the human glucocorticoid receptor, Cell 46, 645-652.
34. Heikinheimo, O. and Kekkonen, R. (1993) Dose-response relationships of RU486, Ann. Med. 25, 71-76.
35. Heikinheimo, O., Lahteenmaki, P. and Koivunen, E. (1987) Metabolism and serum binding of RU486 in women after various single doses, Hum. Reprod. 2, 379-385.
36. Hers, H.G. and Stalmans, W. (1970) The control of glycogen metabolism in liver, FEBS Lett. 12, 73-82.
37. Hollenberg, S.M. and Evans, R.M. (1988) Multiple and cooperative transactivation domains of the human glucocorticoid receptor, Cell 55, 899-906.
38. Holsboer, F. (2001) Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy, J. Affect Disord. 62, 77-91.
39. Holsboer, F. and Barden, N. (1996) Antidepressants and hypothalamic-pituitary-adrenocortical regulation, Endocr. Rev. 17, 187-205.
40. Hoshino, Y., Yokoyama, F., Watanabe, M., Murata, S., Kaneko, M. and Kumashiro, H. (1987) The diurnal variation and response to dexamethasone suppression test of saliva cortisol level in autistic children, Jap. J. Psychiatr. Neurol. 41, 227-235.
41. Jones, M.T. and Hillhouse, E.W. (1976) Structure-activity relationship and the mode of action of corticosteroid feedback on the secretion of corticotrophin-releasing factor (corticoliberin), J. Steroid Biochem. 7, 1189-1202.
42. Kaltsas, G., Manetti, L. and Grossman, A.B. (2002) Osteoporosis in Cushing's syndrome, Front. Harm. Res. 30, 60-72.
43. Karssen, A.M., Meijer, O.C., Van der Sandt, I.C., Lucassen, P.J., de Lange, E.G., de Boer, A.G. and de Kloet, E.R. (2001) Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain, Endocrinology 142, 2686-2694.
44. Karssen, A.M., Meijer, O.G., Van der Sandt, I.C., de Boer, A.G., de Lange, E.C. and de Kloet, E.R. (2002) The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone, J. Endocrinol. 175, 251-260.
45. Kling, M.A., Demitrack, M.A., Whitfield, H.J., Kalogeras, K.T., Listwak, S.J., DeBellis, M.D., Chrousos, G.P., Gold, P.W. and Brandt, H.A. (1993) Effects of the glucocorticoid antagonist RU486 on pituitary-adrenal function in patients with anorexia nervosa and healthy volunteers, enhancement of plasma ACTH and cortisol secretion in underweight patients, Neuroendocrinology 57, 1082-1091.
46. de Kloet, E.R. (1992) Corticosteroids, stress and aging, Ann. NY Acad. Sci. 663, 357-371.
47. Kloosterboer, H.J., Deckers, G.H.J., Heuvel Van der, M.J. and Loozen, H.J.J. (1988) Screening of antiprogestagens by receptor studies and bioassays, J. Steroid. Biochem. 31, 567-571.
48. Krishnan, K.R., Reed, D., Wilson, W.H., Saunders, W.B., Ritchie, J.C., Nemeroff, C. and Carroll, B.J. (1992) RU486 in depression, Prog. Neuro-Psychopharmacol. Biol. Psychiat. 16, 913-9120.
49. Kumar, R. and Thompson, E.B. (1999) The structure of the nuclear hormone receptors, Steroids 64, 310-319.
50. Lammers, C.H., Garcia-Borreguero, D., Schmider, J., Gotthardt, U., Dettling, M., Holsboer, F. and Heuser, I.J. (1995) Combined dexamethasone/ corticotrophin-releasing hormone test in patients with schizophrenia and in normal controls, II, Biol. Psychiatry 38, 803-807.
51. Lemesle-Varloot, L., Ojasoo, T., Mornon, J.P. and Raynaud, J.P. (1992) A model for the determination of the 3D-spatial distribution of the functions of the hormone-binding domain of receptors that bind 3-keto-4-ene steroids, J. Steroid Biochem. Mol. Biol. 41, 369-388.
52. Link, J.T., Sorensen, B.K., Lai, C., Wang, J., Fung, S., Deng, D., Emery, M., Carroll, S., Grynfarb, M., Goos-Nilsson, A. and Von Geldern, T. (2004) Synthesis, activity, metabolic stability, and pharmacokinetics of glucocorticoid receptor modulator-statin hybrids, Bioorg. Med. Chem. Lett. 14, 4173-4178.
53. Litchfield, W.R., Hunt, S.C., Jeunemaitre, X., Fisher, N.D., Hopkins, P.N., Williams, R.R., Corvol, P. and Williams, G.H. (1998) Increased urinary free cortisol, a potential intermediate phenotype of essential hypertension, Hypertension 31, 569-574.
54. Mantero, F. and Boscaro, M. (1992) Glucocorticoid-dependent hypertension, J. Steroid Biochem. Mol. Biol. 43, 409-413.
55. Marchesi, C., Chiodera, P., Ampollini, P., Volpi, R. and Coiro, V. (1997) Beta-endorphin, adrenocorticotropic hormone and cortisol secretion in abstinent alcoholics, Psychiatry Res. 72, 187-194.
56. Miller, A.H., Sastry, G., Speranza, A.J., Lawlor, B.A., Mohs, R.C., Ryan, T.M., Gabriel, S.M., Serby, M., Schmeidler, J. and Davis, K.L. (1994) Lack of association between cortisol hyperscretion and nonsuppression on the DST in patients with Alzheimer's disease, Am. J. Psychiatry 151, 267-270.
57. Miner, J.N., Tyree, C., Hu, J., Berger, E., Marschke, K., Nakane, M., Coghlan, M.J., Clemm, D., Lane, B. and Rosen, J. (2003) A nonsteroidal glucocorticoid receptor antagonist, Mol. Endocrinol. 17, 117-127.
58. Mornon, J.P., Bissery, V., Gaboriaud, C., Thomas, A., Ojasoo, T. and Raynaud, J.P. (1989) Hydrophobic cluster analysis (HCA) of the hormone-binding domain of receptor proteins, J. Steroid Biochem. 34, 355-361.
59. Murphy, B.E. (1991) Steroids and depression, J. Steroid Biochem. Mol. Biol. 38, 537-559.
60. Naylor, P.H. and Rosen, F. (1982) Antiglucocorticoids, differential antagonism of in vivo responses to dexamethasone, In: Agarwal, M.K., (ed.), Hormone antagonists (Walter de Gruyter, Berlin), pp 365-380.
61. Naylor, P.H., Gilani, S.S., Milholland, R.J. and Rosen, F. (1980) Antiglucocorticoids, in vivo assay and evaluation of cortexolone, progesterone and 6-β-bromoprogesterone, Endocrinology 107, 117-121.
62. Neef, G., Beier, S., Elger, W., Henderson, D. and Wiechert, R. (1984) New steroids with antiprogestational and antiglucocorticoid activity, Steroids 44, 349-372.
63. Neidhart, M. (1996) Elevated serum prolactin or elevated prolactin / cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases, J. Rheumatol. 23, 476-481.
64. Nelson, J.C. and Davis, J.M. (1997) DST studies in psychotic depression, a meta-analysis, Am. J. Psychiatry 154, 1497-1503.
65. Nieman, L.K., Chrousos, O.P. and Nisula, B.C. (1985) Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU486, J. Clin. Endocrinol. Metab. 61, 536-540.
66. Nieman, L.K., Udelsman, R., Loriaux, D.L. and Chrousos, C.P. (1987) Antiglucocorticoids, basic and clinical studies, In: D'Agata, R. and Chrousos, G.P. (eds), Recent advances in adrenal regulation and function (Raven Press, New York), pp 235-258.
67. Olefsky, J. and Kimmerling, G. (1976) Effects of glucocorticoids on carbohydrate metabolism, Am. J. Med. Sci. 271, 202-210.
68. Ottow, E., Beier, S., Elger, W., Henderson, D.A., Neef, G. and Wiechert, R. (1984) Synthesis of ent-17-(prop-1-ynyl-17β-hydroxy-11β-(4-N,N- dimethylamino)-phenyl)-4,9-estradien-3-one, the antipode of RU38486, Steroids 44, 519-530.
69. Pariante, C.M., Thomas, S.A., Lovestone, S., Makoff, A. and Kerwin, R.W. (2004) Do antidepressants regulate how cortisol affects the brain?, Psychoneuroendocrinol. 29, 423-447.
70. Parker, K.J., Schatzberg, A.F. and Lyons, D.M. (2003) Neuroendocrine aspects of hypercortisolism in major depression, Horm. Behav. 43, 60-66.
71. Pearson Murphy, B.E., Filipini, D. and Ghadirian, A.M. (1993) Possible use of glucocorticoid receptor antagonists in the treatment of major depression, preliminary results using RU486, J. Psychiatr. Neurosci. 18, 209-213.
72. Peeters, B.W. and Broekkamp, C.L. (1994) Involvement of corticosteroids in the processing of stressful life-events. A possible implication for the development of depression, J. Steroid Biochem. Mol. Biol. 49, 417-427.
73. Pelaia, G., Vatrella, A., Cuda, G., Maselli, R. and Marsico, S.A. (2003) Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases, Life Sci. 72, 1549-1561.
74. Philibert, D., Costerousse, G., Gaillard-Moguilewsky, M., Nedelec, L., Nique, F., Tournemine, C. and Teutsch, G. (1991) From RU38486 towards dissociated antiglucocorticoid and antiprogesterone, In: Agarwal, M.K. (ed.), Antihormones in Health and Disease (Karger, Basel), pp 1-17.
75. Pons, M. and Gagne, D. (1988) A model of antiglucocorticoid action for designing a potent glucocorticoid antagonist, J. Steroid Biochem. 29, 239-247.
76. Poortman, J., Vroegindewey-Jie, D., Thyssen, J.H. and Schwarz, F. (1977) Relative binding affinity of androstane and C-19-norandrostane-steroids for the estradiol-receptor in human myometrial and mammary cancer tissue, Mol. Cell. Endocrinol. 8, 27-34.
77. Reul, J.M. and de Kloet, E.R. (1985) Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation, Endocrinology 117, 2505-2511.
78. Richdale, A.L. and Prior, M.R. (1992) Urinary cortisol circadian rhythm in a group of high-functioning children with autism, J. Autism Dev. Disord. 22, 433-447.
79. Rousseau, G.G., Cambron, P., Brasseur, N., Marcotte, L., Matton, P. and Schmit, J.P. (1983) Glucocorticoid agonist and antagonist activity of 17,21-acetonide steroids, J. Steroid Biochem. 18, 237-244.
80. Roy, M.S., Roy, A. and Brown, S. (1998) Increased urinary-free cortisol outputs in diabetic patients, J. Diabetes Complications 12, 24-27.
81. Rupprecht, R., Arriza, J.L., Spengler, D., Reul, J.M.H.M., Evans, R.M., Holsboer, F. and Damm, K. (1993) Trans-activation and synergistic properties of the mineralocorticoid receptor, relationship to the glucocorticoid receptor, Mol. Endocrinol. 7, 597-603.
82. Rupprecht, R., Reul, J.M.H.M., van Steensel, B., Spengler, D., Soder, M., Berning, B., Holsboer, F. and Damm, K. (1993) Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligands, Eur. J. Pharmacol. 247, 145-154.
83. Sacco, M., Valenti, G., Corvi Mora, P., Wu, F.C. and Ray, D.W. (2002) DHEA, a selective glucocorticoid receptor antagonist: its role in immune system regulation and metabolism, J. Endocrinol. Investig. 25, 81-82.
84. Sakiz, E. (1987) Survey of antiglucocorticoids, In: Furr, B.J. and Wakeling, A.E. (eds), Pharmacology and Clinical Uses of Inhibitors of Hormone Secretion and Action (Bailliere-Tindall, London), pp 213-233.
85. Sapolsky, R.M. (2000) Glucocorticoids and hippocampal atrophy in neuropsychiatrie disorders, Arch. Gen. Psychiatry 57, 925-935.
86. Sarkar, N.N. (2002) Mifepristone: bioavailability, pharmacokinetics and use-effectiveness, Eur. J. Obstet. Gynaecol. Reprod. Biol. 101, 113-120.
87. Schatzberg, A.F. (2003) New approaches to managing psychotic depression, J. Clin. Psychiatry 64(S1), 19-23.
88. Scheible, P.P., DeLorenzo, T.M. and Cidlowski, J.A. (1987) Analysis of the glucocorticoid antagonist action of dexamethasone 21-mesylate in HeLa S3 cells, J. Steroid Biochem. 26, 181-187.
89. Sennef, C., Hoyberg, O.J., Wik, G., Mehtonen, O.P. and Peeters, B.W.M.M. (2002) Org 34517, a selective glucocorticoid receptor antagonist with strong antidepressant activity in man: first clinical results. First Dutch Endo-Neuro-Psycho Meeting, Doorwerth.
90. Shiau, A.K., Barstad, D., Loria, P.M., Cheng, L., Kushner, P.J., Agard, D.A. and Greene, G.L. (1998) The structural basis of estrogen/coactivator recognition and the antagonism of this interaction by tamoxifen, Cell 95, 927-937.
91. Simons, S.S. and Miller, P.A. (1986) Affinity-labeling steroids as biologically active probes of antiglucocorticoid hormone action, J. Steroid Biochem. 24, 25-32.
92. Sorensen, B.K., Link, J.T., von Geldern, T., Emery, M., Wang, J., Hickman, B., Grynfarb, M., Goos-Nilsson, A. and Carroll, S. (2003) An evaluation of a C-glucuronide as a liver targeting group: conjugate of a glucocorticoid antagonist, Bioorg. Med. Chem. Lett. 13, 2307-2310.
93. Spitz, I.M., Bardin, C.W., Benton, L. and Robbins, A. (1998) Early pregnancy termination with mifepristone and misoprostol in the United States, N. Engl. J. Med. 338, 1241-1247.
94. Stanimirovic, D.B., McCarron, R.M. and Spatz, M. (1994) Dexamethasone down-regulates endothelin receptors in human cerebromicrovascular endothelial cells, Neuropeptides 26, 145-152.
95. Swaab, D.F., Raadsheer, F.C., Endert, E., Hofman, M.A., Kamphorst, W. and Ravid, R. (1994) Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid, J. Neuroendocrinol. 6, 681-687.
96. Tanenbaum, D.M., Wang, Y., Williams, S.P. and Sigler, P.B. (1998) Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains, Proc. Natl Acad. Sci. USA 95, 5998-6003.
97. Teutsch, G., Gaillard-Moguilewsky, M., Lemoine, G., Nique, F. and Philibert, D. (1991) Design of ligands for the glucocorticoid and progestin receptors, Bioch. Soc. Trans. 19, 901-908.
98. Tordjman, S., Anderson, G.M., McBride, P.A., Hertzig, M.E., Snow, M.E., Hall, L.M., Thompson, S.M., Ferrari, P. and Cohen, D.J. (1997) Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism, J. Child Psychol. Psychiat. Allied Discov. 38, 705-715.
99. Tsigos, C. and Chrousos, G.P. (2002) Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress, J. Psychosom. Res. 53, 865-871.
100. Van der Lely, A.J., Foeken, K., Van der Mast, R.C. and Lamberts, S.W.J. (1991) Rapid reversal of acute psychosis in the Gushing syndrome with the cortisol-receptor antagonist Mifepristone (RU486), Ann. Int. Med. 114, 143-144.
101. Williams, S.P. and Sigler, P.B. (1998) Atomic structure of progesterone complexed with its receptor, Nature 393, 392-396.
102. Wolff, J.E., Laterra, J. and Goldstein, G.W. (1992) Steroid inhibition of neural microvessel morphogenesis in vitro, receptor mediation and astroglial dependence, J. Neurochem. 58, 1023-1032.